We report that the successful anti-inflammatory treatment of RA with TNFαI exerts a chondroprotective effect on cartilage turnover, improving the ratios of type II collagen resorption/formation (C2C/PIICP) in the evaluation of anti-TNF-α therapeutic response in RA patients. The gene discussed is TNF; the disease is rheumatoid arthritis.